Neuromodulation for the Treatment of Refractory Ventricular Arrhythmias

Neuromodulation for the Treatment of Refractory Ventricular Arrhythmias - JCEP February 2023

Description

Neuromodulation is increasingly recognized as a therapeutic strategy for patients with refractory ventricular arrhythmias (VAs). Percutaneous stellate ganglion blockade (SGB), transcutaneous magnetic stimulation (TcMS), and surgical cardiac sympathetic denervation (CSD) have all been utilized in this setting.

Editor-in-Chief

Kalyanam Shivkumar, MD, PhD, FACC

CME Editor
Kenneth A. Ellenbogen, MD, FACC

Author
Mahmoud Houmsse, MD, FACC

Important Dates
Date of Release: February 27, 2023
Term of Approval/Date of CME/MOC Expiration: February 26, 2024

Summary


Availability:	Retired


Cost:	FREE


Credit Offered:	No Credit Offered